Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
Journal of Magnetic Resonance Imaging,  Clinical Article

Chang YC et al. – Dynamic contrast–enhanced (DCE) magnetic resonance imaging (MRI) enables a functional analysis of the treatment response of nonsmall–cell lung cancer (NSCLC). MRI parametric histogram has the potential to predict early treatment response of combined bevacizumab, gemcitabine, and cisplatin.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Radiology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Radiology Articles

Indexed Journals in Radiology: Clinical Radiology, American Journal of Roengenology, Academic Radiologymore